(Q46710238)

24 December 2017

title

Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression (English)

1 reference

24 December 2017

author

Michael Berk

series ordinal

3

1 reference

24 December 2017

Gin Malhi

series ordinal

1

object named as

Gin S Malhi

1 reference

24 December 2017

author name string

Felicity Ng

series ordinal

2

1 reference

24 December 2017

publication date

1 April 2008

1 reference

24 December 2017

Australian and New Zealand Journal of Psychiatry

published in

1 reference

24 December 2017

volume

42

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

346-349

1 reference

24 December 2017

Judged effectiveness of differing antidepressant strategies by those with clinical depression.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

Use of antidepressant combinations: which, when and why? Results of a Spanish survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

To combine or not to combine? A literature review of antidepressant combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

Combination pharmacotherapy in unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

Combined antidepressants: clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

Antidepressants: prevalence of duplicate therapy and avoidable drug interactions in Australian veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

fMRI during affect discrimination in bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

Medication augmentation after the failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

A Survey of Combination Antidepressant Use in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701881587

10.1080/00048670701881587

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017